BBusiness Read More Wegovy-maker Novo Nordisk to cut around 9,000 jobsSeptember 10, 2025 Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
UUnited States Read More Trump administration has backup plans for tariffsSeptember 2, 2025 Scott Bessent, US treasury secretary, in the Oval Office of the White House in Washington, DC, US, on…
BBusiness Read More Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drugAugust 24, 2025 A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
BBusiness Read More FDA approves Signos glucose monitoring for weight lossAugust 20, 2025 Woman with Signos wearable and app Source: Signos The Food and Drug Administration on Wednesday approved the first-ever…
MMarkets Read More Here are 3 stocks that are working in Thursday’s mixed market and another that is notAugust 7, 2025 Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
BBusiness Read More Novo Nordisk (NVO) earnings Q2 2025August 6, 2025 Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…
MMarkets Read More Jim Cramer’s top 10 things to watch in the stock market WednesdayJuly 30, 2025 My top 10 things to watch Wednesday, July 30 1. Wall Street is on pace for a flat…
BBusiness Read More Novo Nordisk shares plunge after Wegovy-maker cuts full-year guidanceJuly 29, 2025 Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the…
HHealth Read More Researchers move closer to a universal cancer vaccineJuly 24, 2025 Wildpixel | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter,…
HHealth Read More Weight loss drugs could help treat PCOSJuly 20, 2025 Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
BBusiness Read More It’s all about the guidanceJuly 17, 2025 Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left…